JAMES MCHUGH - 06 Dec 2021 Form 3 Insider Report for EXELON CORP (EXC)

Role
EVP & Chief Commercial Officer
Signature
Elizabeth M. Hensen, Attorney-in-Fact for James McHugh
Issuer symbol
EXC
Transactions as of
06 Dec 2021
Net transactions value
$0
Form type
3
Filing time
14 Dec 2021, 16:10:04 UTC
Next filing
16 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding EXC Common Stock 25,598 06 Dec 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding EXC Restricted Stock Unit Award (02/04/2019) 06 Dec 2021 Common stock 4,275 Direct F1
holding EXC Restricted Stock Unit Award (01/27/2020) 06 Dec 2021 Common stock 8,301 Direct F2
holding EXC Restricted Stock Unit Award (01/25/2021) 06 Dec 2021 Common stock 13,068 Direct F3
holding EXC Restricted Stock Unit Award (04/05/2021) 06 Dec 2021 Common stock 20,318 Direct F4
holding EXC Deferred Phantom Shares 06 Dec 2021 Common stock 2,175 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Remaining 1/3 increment of annual restricted stock unit (RSU) award granted in February, 2019 pursuant to the Exelon Long Term Incentive Plan; each award vests in 1/3 increments on the date of the Compensation & Leadership Development Committee's January or February meeting in the first, second and third years after the award was granted. Award balances accrue additional units through automatic dividend reinvestment, which vest on the same schedule as the underlying award.
F2 Remaining 2/3 increment of annual RSU award granted in January, 2020 pursuant to the Exelon Long Term Incentive Plan; each award vests in 1/3 increments on the date of the Compensation & Leadership Development Committee's January or February meeting in the first, second and third years after the award was granted. Award balances accrue additional units through automatic dividend reinvestment, which vest on the same schedule as the underlying award.
F3 Annual RSU award granted in January 2021 pursuant to the Exelon Long Term Incentive Plan; each award vests in 1/3 increments on the date of the Compensation & Leadership Development Committee's January or February meeting in the first, second and third years after the award was granted. Award balances accrue additional units through automatic dividend reinvestment, which vest on the same schedule as the underlying award.
F4 Restricted stock unit award granted pursuant to the Exelon LTI plan. All shares will cliff vest on April 5, 2025. Award balance accrue additional units through automatic dividend reinvestment which will vest on the same schedule as the underlying award. .
F5 Phantom share equivalents held as of November 30, 2021 representing units held in the Exelon stock fund in a multi-fund, non-qualified deferred compensation plan. The Exelon stock fund is a unitized fund that consists of Exelon common stock and short term investments. Units of the fund will be settled upon the reporting person's separation from the company for any reason. Units will be settled in cash. Units are acquired through regular periodic contributions, company matching contributions and the reinvestment of dividend equivalents. The balance of phantom share equivalents may fluctuate due to periodic changes in the fund composition.